Is psoriasis a neuroimmunologic disease?

International Journal of Dermatology

Volumn 38, Issue 1, 1999, Pages 12-15

  Farber, Eugene M ^a   Raychaudhuri, Siba P ^a  

^a Psoriasis Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NEUROPEPTIDE; RANTES; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

CELL PROLIFERATION; CLINICAL FEATURE; GENE EXPRESSION REGULATION; HUMAN; KERATINOCYTE; MAST CELL DEGRANULATION; NEUROGENIC INFLAMMATION; NEUROIMMUNOLOGY; NEUTROPHIL CHEMOTAXIS; PSORIASIS; REVIEW; SKIN INFLAMMATION; T LYMPHOCYTE ACTIVATION;

HUMANS; IMMUNE SYSTEM DISEASES; NERVE GROWTH FACTORS; NERVOUS SYSTEM DISEASES; PSORIASIS; SKIN; T-LYMPHOCYTES;

EID: 0032925946     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1999.00635.x     Document Type: Review

References (35)

1. Farber EM, Nickoloff BJ, Recht B, et al. Stress, symmetry and psoriasis: possible role of neuropeptides. J Am Acad Dermatol 1986; 14: 305-311.
2. Raychaudhuri SP, Farber EM. Are sensory nerves essential for the development of psoriasis lesions? J Am Acad Dermatol 1993; 28: 488-489.
3. Naukkarinen A, Nickoloff BJ, Farber EM. Quantification of cutaneous sensory nerves and their substance P content in psoriasis. J Invest Dermatol 1989; 92: 126-129.
4. Al'Abadie MSK, Senior HJ, Bleehen SS, et al. Neurogenic changes in psoriasis. An immunohistochemical study. J Invest Dermatol 1992; 98: 535.
5. Wallengren J, Ekman R, Sunder F. Occurrence and distribution of neuropeptides in human skin. An immunocytochemical and immunohistochemical study on normal skin and blister fluid from inflamed skin. Acta Derm Venereol (Stockh) 1987; 67: 185-191.
6. Raychaudhuri SP, Jiang W-Y, Farber EM. Psoriatic keratinocytes express high levels of nerve growth factor. Acta Derm Venereol 1998; 78: 84-86.
7. Fantini F, Magnoni C, Brauci-Laudeis L, Pincelli C. Nerve growth factor is increased in psoriatic skin. J Invest Dermatol 1995; 105: 854-855.
8. Bos JD, Hulsebosch HJ, Krieg SR, et al. Immunocompetent cells in psoriasis: in situ immunophenotyping with monoclonal antibodies. Arch Dermatol Res 1983; 275: 181-189.
9. Valdimarsson H, Baker BS, Jonsdottir I, et al. Psoriasis: a disease of abnormal keratinocyte proliferation induced by T lymphocytes. Immunol Today 1986; 7: 256-259.
10. Chang JCC, Smith LR, Froning KJ, et al. Persistence of T-cell clones in psoriatic lesions. Arch Dermatol 1997; 133: 703-708.
11. Ansel JC, Kaynard AH, Armstrong CA, et al. Skin-nervous system interactions. Dermatology Foundation 1995; 29: 1-12.
12. Diamond J, Holmes M, Coughin M. Endogenous NGF and nerve impulses regulate the collateral sprouting of sensory axons in the skin of the adult rat. J Neurosci 1992; 12: 1454-1466.
13. Jiang W-Y, Raychaudhuri SP, Farber EM. Double labeled immunofluorescence study of cutaneous nerves in psoriasis. Int J Dermatol 1998; 37: 572-574.
14. Haegerstrand A, Jonzon B, Dalsgaard CJ et al. Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes. Proc Natl Acad Sci USA 1989; 86: 5993-5996.
15. Wilkinson DI. Mitogenic effect of substance P and CGRP on keratinocytes. J Cell Biol 1989; 107: 509a.
16. Hagerstrand A, Dalsgaard CJ, Jonzon B, et al. Calcitonin gene-related peptide stimulates proliferation of human endothelial cells. Proc Natl Acad Sci USA 1990; 87: 3299-3303.
17. Tomoe S, Iwamoto I, Tomioka H, et al. Comparison of substance P-induced and compound 48/80 induced neutrophil infiltrates in mouse skin. Int Arch Allergy Appl Immunol 1991; 97: 237-242.
18. Smith HC, Barker JN, Morris RW, et al. Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin. J Immunol 1993; 151: 3274-3282.
19. Calvo CF, Chavanel G, Senik A. Substance P enhances interleukin-2 expression in activated human T cells. J Immunol 1992; 148: 3498-3504.
20. Matis WL, Lavker RM, Murphy GF. Substance P induces the expression of an endothelial leukocyte adhesion molecule by microvascular endothelium. J Invest Dermatol 1990; 33: 492-495.
21. Wyatt S, Shooeter EM, Davies AM. Expression of the NGF receptor gene in sensory neurons and their cutaneous targets prior to and during innervation. Neuron 1990; 2: 421-427.
22. Lindsay RM, Harmar AJ. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 1989; 337: 362-364.
23. Schwartz J, Pearson J, Johnson E. Effect of exposure to anti-NGF on sensory neurons of adult rats and guinea pigs. Brain Res 1982; 244: 378-381.
24. Farber EM, Chan J, Raychaudhuri SP, Smoller BR. Increased nerve growth factor receptor (NGF-R) in papillary dermis of lesional psoriatic skin: further evidence for a role of the sensory nervous systems in the pathogenesis of psoriasis. Br J Dermatol 1996; 135: 841.
25. Wilkinson DI, Theeuwes MI, Farber EM. Nerve growth factor increases the mitogenicity of certain growth factors for cultured human keratinocytes: a comparison with epidermal growth factor. Exp Dermatol 1994; 3: 239-245.
26. Pincelli C, Haake AR, Benassi L, et al. Autocrine nerve growth factor protects human keratinocytes from apoptosis through its high affinity receptor (TRK): a role for BCL-2. J Invest Dermatol 1997; 109: 757-764.
27. Aloe L, Levi-Mantalcini R. Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res 1077; 133: 358-366.
28. Pearce FL, Thompson HL. Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor. J Physiol 1986; 372: 379-393.
29. Thorpe LW, Werrbach-Perez K, Perez-Polo JR. Effects of nerve growth factor on the expression of IL-2 receptors on cultured human lymphocytes. Ann NY Acad Sci 1987; 496: 310-311.
30. Bischoff SC, Dahinden CA. Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood 1992; 779: 2662-2669.
31. Lambiase A, Bracci-Laudiero L, Bonini S, et al. Human CD4+ T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors. J Allergy Clin Immunol 1997; 100: 408-414.
32. Wrone-Smith T, Nickoloff BJ. Dermal injection of immunocytes induces psoriasis. J Clin Invest 1996; 98(8): 1878-1887.
33. Raychaudhuri SP, Jiang W-Y, Eugene EM, et al. Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasis. Acta Derm Venereol (Stockh) (in press).
34. Pattison JM, Nelson PJ, Huie P, et al. RANTES chemokine expression in cell mediated transplant rejection of the kidney. Lancet 1994; 343: 209-211.
35. Schall TJ. Biology of the RANTES/SIS cytokine family. Cytokine 1991; 3: 165-183.